Guangying Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Guangying Zheng has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Hua-Jun Wang
Jinan University, The First Affiliated Hospital, Department of Bone and Joint Surgery and Sports Medicine Center, Guangzhou, 510630 China
1 shared publication - Huajun Wang
Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou City, Henan Province, China
1 shared publication - Huajun Wang
Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450000, Henan, China
1 shared publication - Miaomiao Sun
Department of Dermatology Xiangyang Hospital of Traditional Chinese Medicine Xiangyang China
1 shared publication Yingjie Chi
Department of Ophthalmology The First Affiliated Hospital of Zhengzhou University Zhengzhou City Henan China
1 shared publication
Latest Publications
- 21 June 2022
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 36 (9) , e23144
Circ‐POLR3A accelerates TGF‐β2‐induced promotion in cell viability, migration, and invasion of lens epithelial cells via miR‐31/TXNIP signaling cascade
Posterior capsular opacification (PCO) is the major complication after cataract surgery and can result in secondary vision loss. Circular RNAs (circRNAs) are reported to play critical regulatory roles in multiple cell biological processes. The most common working mechanism of circRNAs is by acting as microRNA sponges. Here, we analyzed the role and mechanism of circRNA RNA polymerase III subunit A (POLR3A) in PCO. Cell viability was analyzed by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide assay. Cell motility was assessed by transwell and wound healing assays. Dual‐luciferase reporter and RNA‐pull‐down assays were performed to verify the interaction between microRNA‐31 (miR‐31) and circ‐POLR3A or thioredoxin interacting protein (TXNIP). PCO cell model was established by treating SRA01/04 cells with transforming growth factor‐β2 (TGF‐β2). We found that TGF‐β2 enhanced SRA01/04 cell viability, migration, and invasion abilities. Circ‐POLR3A expression was upregulated in PCO tissues and TGF‐β2‐induced SRA01/04 cells. TGF‐β2 promoted the viability and motility of SRA01/04 cells largely by upregulating circ‐POLR3A. Circ‐POLR3A negatively regulated the miR‐31 level by directly interacting with it. Circ‐POLR3A absence‐induced influences in TGF‐β2‐induced SRA01/04 cells were partly reversed by silencing miR‐31. miR‐31 is directly bound to the 3′‐untranslated region of TXNIP. TXNIP overexpression largely attenuated miR‐31 overexpression‐mediated effects in TGF‐β2‐induced SRA01/04 cells. Circ‐POLR3A could elevate the protein expression of TXNIP by sponging miR‐31. Exosomes were involved in mediating the delivery of circ‐POLR3A in SRA01/04 cells. In conclusion, circ‐POLR3A contributed to TGF‐β2‐induced promotion of cell viability, migration, and invasion of SRA01/04 cells by targeting miR‐31/TXNIP axis.
- 21 June 2022
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 36 (9) , e23144
Circ‐POLR3A accelerates TGF‐β2‐induced promotion in cell viability, migration, and invasion of lens epithelial cells via miR‐31/TXNIP signaling cascade
Posterior capsular opacification (PCO) is the major complication after cataract surgery and can result in secondary vision loss. Circular RNAs (circRNAs) are reported to play critical regulatory roles in multiple cell biological processes. The most common working mechanism of circRNAs is by acting as microRNA sponges. Here, we analyzed the role and mechanism of circRNA RNA polymerase III subunit A (POLR3A) in PCO. Cell viability was analyzed by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide assay. Cell motility was assessed by transwell and wound healing assays. Dual‐luciferase reporter and RNA‐pull‐down assays were performed to verify the interaction between microRNA‐31 (miR‐31) and circ‐POLR3A or thioredoxin interacting protein (TXNIP). PCO cell model was established by treating SRA01/04 cells with transforming growth factor‐β2 (TGF‐β2). We found that TGF‐β2 enhanced SRA01/04 cell viability, migration, and invasion abilities. Circ‐POLR3A expression was upregulated in PCO tissues and TGF‐β2‐induced SRA01/04 cells. TGF‐β2 promoted the viability and motility of SRA01/04 cells largely by upregulating circ‐POLR3A. Circ‐POLR3A negatively regulated the miR‐31 level by directly interacting with it. Circ‐POLR3A absence‐induced influences in TGF‐β2‐induced SRA01/04 cells were partly reversed by silencing miR‐31. miR‐31 is directly bound to the 3′‐untranslated region of TXNIP. TXNIP overexpression largely attenuated miR‐31 overexpression‐mediated effects in TGF‐β2‐induced SRA01/04 cells. Circ‐POLR3A could elevate the protein expression of TXNIP by sponging miR‐31. Exosomes were involved in mediating the delivery of circ‐POLR3A in SRA01/04 cells. In conclusion, circ‐POLR3A contributed to TGF‐β2‐induced promotion of cell viability, migration, and invasion of SRA01/04 cells by targeting miR‐31/TXNIP axis.
- Open Access
- 31 October 2020
- Published by Springer Nature in Cancer Cell International
- Vol. 20 (1) , 1-12
LncRNA NEAT1 promotes proliferation, migration, invasion and epithelial-mesenchymal transition process in TGF-β2-stimulated lens epithelial cells through regulating the miR-486-5p/SMAD4 axis
Background: Abnormal proliferation, metastasis and epithelial-mesenchymal transformation (EMT) of lens epithelial cells (LECs) are direct factors of posterior capsular opacification (PCO). Nuclear enriched abundant transcript 1 (NEAT1) has been shown to promote cell proliferation, metastasis and EMT, but whether it affects the progression of PCO is unclear. Methods: The expression of NEAT1, microRNA-486-5p (miR-486-5p) and Drosophila mothers against decapentaplegic 4 (SMAD4) was determined using quantitative real-time polymerase chain reaction (qRT-PCR). The proliferation of cells was measured via 3-(4, 5-dimethyl-2 thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay. Transwell assay was employed to detect the migration and invasion of cells. The levels of EMT marker proteins, SMAD4 protein and transforming growth factor-β (TGF-β)/SMAD signaling pathway-related proteins were assessed by western blot (WB) analysis. Further, the relationship between miR-486-5p and NEAT1 or SMAD4 was confirmed by dual-luciferase reporter assay, RNA immunoprecipitation (RIP) assay and biotin-labeled RNA pull-down assay. Results: NEAT1 is upregulated and miR-486-5p is downregulated in the posterior capsular tissues of PCO patients and TGF-β2-induced LECs. Interference of NEAT1 reverses the promoting effect of TGF-β2 on the proliferation, migration, invasion and EMT of LECs. MiR-486-5p can be sponged by NEAT1, and its inhibitor reverses the suppression effect of NEAT1 silencing on the progression of TGF-β2-induced LECs. SMAD4 functions as a target of miR-486-5p, and its overexpression recovers the inhibition effect of miR-486-5p overexpression on the progression of TGF-β2-induced LECs. The activity of the TGF-β/SMAD signaling pathway is regulated by the NEAT1/miR-486-5p/SMAD4 axis. Conclusion: Our study shows that NEAT1 has a positive effect on the progression of PCO and is expected to become a new target for PCO treatment.
- 31 October 2020
- Published by Springer Nature in Cancer Cell International
- Vol. 20 (1) , 1-12
Open AccessLncRNA NEAT1 promotes proliferation, migration, invasion and epithelial-mesenchymal transition process in TGF-β2-stimulated lens epithelial cells through regulating the miR-486-5p/SMAD4 axis
Background: Abnormal proliferation, metastasis and epithelial-mesenchymal transformation (EMT) of lens epithelial cells (LECs) are direct factors of posterior capsular opacification (PCO). Nuclear enriched abundant transcript 1 (NEAT1) has been shown to promote cell proliferation, metastasis and EMT, but whether it affects the progression of PCO is unclear. Methods: The expression of NEAT1, microRNA-486-5p (miR-486-5p) and Drosophila mothers against decapentaplegic 4 (SMAD4) was determined using quantitative real-time polymerase chain reaction (qRT-PCR). The proliferation of cells was measured via 3-(4, 5-dimethyl-2 thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay. Transwell assay was employed to detect the migration and invasion of cells. The levels of EMT marker proteins, SMAD4 protein and transforming growth factor-β (TGF-β)/SMAD signaling pathway-related proteins were assessed by western blot (WB) analysis. Further, the relationship between miR-486-5p and NEAT1 or SMAD4 was confirmed by dual-luciferase reporter assay, RNA immunoprecipitation (RIP) assay and biotin-labeled RNA pull-down assay. Results: NEAT1 is upregulated and miR-486-5p is downregulated in the posterior capsular tissues of PCO patients and TGF-β2-induced LECs. Interference of NEAT1 reverses the promoting effect of TGF-β2 on the proliferation, migration, invasion and EMT of LECs. MiR-486-5p can be sponged by NEAT1, and its inhibitor reverses the suppression effect of NEAT1 silencing on the progression of TGF-β2-induced LECs. SMAD4 functions as a target of miR-486-5p, and its overexpression recovers the inhibition effect of miR-486-5p overexpression on the progression of TGF-β2-induced LECs. The activity of the TGF-β/SMAD signaling pathway is regulated by the NEAT1/miR-486-5p/SMAD4 axis. Conclusion: Our study shows that NEAT1 has a positive effect on the progression of PCO and is expected to become a new target for PCO treatment.